Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study.

de Camargo Cancela M, Comber H, Sharp L.

Br J Cancer. 2013 Jul 9;109(1):272-9. doi: 10.1038/bjc.2013.268. Epub 2013 May 30.

2.

Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.

Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A.

J Gen Intern Med. 2004 Feb;19(2):146-55.

3.

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD.

J Clin Oncol. 2003 Sep 1;21(17):3318-27.

PMID:
12947068
4.

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.

Aizer AA, Chen MH, Hattangadi J, D'Amico AV.

BJU Int. 2014 Jan;113(1):43-50. doi: 10.1111/j.1464-410X.2012.11789.x. Epub 2013 Mar 8.

5.

Is there age bias in the treatment of localized prostate carcinoma?

Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G.

Cancer. 2004 Jan 1;100(1):72-81.

7.

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, Fulton JP, Shen T, Stuckart E.

BMC Cancer. 2010 Apr 19;10:152. doi: 10.1186/1471-2407-10-152.

8.

Is there an optimal comorbidity index for prostate cancer?

Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G.

Cancer. 2008 Mar 1;112(5):1043-50. doi: 10.1002/cncr.23269.

9.

Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA.

J Natl Cancer Inst. 2001 Dec 19;93(24):1864-71.

10.

Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study.

Holmes JA, Wang AZ, Hoffman KE, Hendrix LH, Rosenman JG, Carpenter WR, Godley PA, Chen RC.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):88-94. doi: 10.1016/j.ijrobp.2011.10.076. Epub 2012 Jan 31.

PMID:
22300560
11.
12.

Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

Jeldres C, Suardi N, Walz J, Saad F, Hutterer GC, Bhojani N, Shariat SF, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI.

Eur Urol. 2008 Jul;54(1):107-16. Epub 2007 Oct 30.

PMID:
17996358
13.

Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011.

Evans SM, Millar JL, Davis ID, Murphy DG, Bolton DM, Giles GG, Frydenberg M, Andrianopoulos N, Wood JM, Frauman AG, Costello AJ, McNeil JJ.

Med J Aust. 2013 Jun 3;198(10):540-5.

PMID:
23725268
14.

Radical prostatectomy versus watchful waiting in early prostate cancer.

Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Steineck G, Adami HO, Johansson JE; SPCG-4 Investigators.

N Engl J Med. 2011 May 5;364(18):1708-17. doi: 10.1056/NEJMoa1011967.

15.

[Treating 'healthy' men who have localised cancer of the prostate].

de Jong IJ.

Ned Tijdschr Geneeskd. 2013;157(42):A6703. Dutch.

PMID:
24128601
16.

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.

Miller DC, Gruber SB, Hollenbeck BK, Montie JE, Wei JT.

J Natl Cancer Inst. 2006 Aug 16;98(16):1134-41.

17.

Continued undertreatment of older men with localized prostate cancer.

Schwartz KL, Alibhai SM, Tomlinson G, Naglie G, Krahn MD.

Urology. 2003 Nov;62(5):860-5.

PMID:
14624909
18.

Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.

Daskivich TJ, Lai J, Dick AW, Setodji CM, Hanley JM, Litwin MS, Saigal C; Urologic Diseases in America Project.

Cancer. 2014 Dec 1;120(23):3642-50. doi: 10.1002/cncr.28926. Epub 2014 Jul 17.

19.

Low risk prostate cancer in men ≥ 70 years old: to treat or not to treat.

Rice KR, Colombo ML, Wingate J, Chen Y, Cullen J, McLeod DG, Brassell SA.

Urol Oncol. 2013 Aug;31(6):755-60. doi: 10.1016/j.urolonc.2011.07.004. Epub 2011 Aug 26.

PMID:
21872499
20.

Radical prostatectomy versus watchful waiting for prostate cancer.

Hegarty J, Beirne PV, Walsh E, Comber H, Fitzgerald T, Wallace Kazer M.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006590. doi: 10.1002/14651858.CD006590.pub2. Review.

PMID:
21069689
Items per page

Supplemental Content

Write to the Help Desk